Table 1.

Personalized neoantigen peptides and predicted HLA binding in the enrolled patient

ID	Mutation	Gene	HLA	Peptide_MT	IC50(MT)
chr13_37016372	L426R	CCNA1	HLA-DRB1*12:02	SEIVPCLSERHKAYL	41.73
chr1_234519474	K50N	COA6	HLA-DRB1*12:02	QWINYFDKRRDYLKF	37.43
chr5_54558630	V1219E	DHX29	HLA-A*02:03	LLKAELVAGL	6.8
chr17_45451923	K321N	EFCAB13	HLA-DRB1*12:02	VAGCYLKYKNKNSLS	37.16
chr1_225700405	A706V	ENAH	HLA-DRB1*12:02	EMSALLARRRRIVEK	3.24
chr12_25398284	G12D	KRAS	HLA-A*02:03	KLVVVGADGV	38.1
chr19_42907156	A857E	LIPE	HLA-DRB1*12:02	ALPLSEPMRRSVSEE	536.4
chrX_149828881	I 464S	MTM1	HLA-A*02:03	FLSIILDHL	6.0
chr5_7878221	S216C	MTRR	HLA-DRB1*12:02	RTDLVKSELLHIECQ	39.99
chr7_154753273	Y738C	PAXIP1	HLA-DRB1*12:02	LKLMAYLAGAKYTGC	9.4
chr7_77256204	A403G	PTPN12	HLA-DRB1*12:02	PKPVLHMVSSEQHSG	57.32
chr1_153751670	Y704C	SLC27A3	HLA-A*02:03	FLQEVNVCGV	4.1
chr16_18826602	I 3507F	SMG1	HLA-DRB1*12:02	SFYNNLVSFASPLVT	14.01